VF
EBS icon

Virtu Financial’s Emergent Biosolutions EBS Stock Holding History

Virtu Financial’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,556
Closed -$71K – 1567
2023
Q4 		$71K Buy
29,556
+12,623
+75% +$29.7K 0.01% 1106
2023
Q3 		$58K Buy
+16,933
New +$93.9K 0.01% 892
2021
Q4 		– Sell
-6,281
Closed -$314K – 1827
2021
Q3 		$314K Buy
+6,281
New +$380K 0.03% 693
2021
Q2 		– Sell
-2,557
Closed -$238K – 1641
2021
Q1 		$238K Buy
+2,557
New +$262K 0.02% 964
2019
Q2 		– Sell
-4,714
Closed -$238K – 1547
2019
Q1 		$238K Buy
+4,714
New +$278K 0.01% 910
2018
Q2 		– Sell
-4,280
Closed -$225K – 2084
2018
Q1 		$225K Sell
4,280
-4,869
-53% -$243K 0.01% 1267
2017
Q4 		$425K Buy
+9,149
New +$385K 0.02% 963

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial's EBS Position: Q1 2024 in Review

Virtu Financial sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 29,556 shares — an estimated $71K sold.

Virtu Financial first reported a position in EBS in Q4 2017 and held it in 7 quarters. The position peaked at $425K in Q4 2017. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Virtu Financial reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 29,556 Emergent Biosolutions shares in Q1 2024, an estimated $71K.
  • Virtu Financial first reported a position in Emergent Biosolutions in Q4 2017 and held it in 7 quarters.
  • Virtu Financial's Emergent Biosolutions position peaked at $425K in Q4 2017.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.